Literature DB >> 20385773

Stat5 promotes survival of mammary epithelial cells through transcriptional activation of a distinct promoter in Akt1.

Bradley A Creamer1, Kazuhito Sakamoto, Jeffrey W Schmidt, Aleata A Triplett, Richard Moriggl, Kay-Uwe Wagner.   

Abstract

The signal transducer and activator of transcription 5 (Stat5) plays a pivotal role in the proliferation, secretory differentiation, and survival of mammary epithelial cells. However, there is little information about Stat5 target genes that facilitate these biological processes. We provide here experimental evidence that the prolactin-mediated phosphorylation of Stat5 regulates the transcriptional activation of the Akt1 gene. Stat5 binds to consensus sequences within the Akt1 locus in a growth factor-dependent manner to initiate transcription of a unique Akt1 mRNA from a distinct promoter, which is only active in the mammary gland. Elevating the levels of active Akt1 restores the expression of cyclin D1 and proliferation of Jak2-deficient mammary epithelial cells, which provides evidence that Akt1 acts downstream of Jak/Stat signaling. The ligand-inducible expression of Stat5 in transgenic females mediates a sustained upregulation of Akt1 in mammary epithelial cells during the onset of postlactational involution. Stat5-expressing mammary glands exhibit a delay in involution despite induction of proapoptotic signaling events. Collectively, the results of the present study elucidate an underlying mechanism by which active Stat5 mediates evasion from apoptosis and self-sufficiency in growth signals.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20385773      PMCID: PMC2876679          DOI: 10.1128/MCB.00851-09

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  54 in total

Review 1.  Information networks in the mammary gland.

Authors:  Lothar Hennighausen; Gertraud W Robinson
Journal:  Nat Rev Mol Cell Biol       Date:  2005-09       Impact factor: 94.444

2.  Development of mammary luminal progenitor cells is controlled by the transcription factor STAT5A.

Authors:  Daisuke Yamaji; Risu Na; Yonatan Feuermann; Susanne Pechhold; Weiping Chen; Gertraud W Robinson; Lothar Hennighausen
Journal:  Genes Dev       Date:  2009-10-15       Impact factor: 11.361

3.  IGF-2 is a mediator of prolactin-induced morphogenesis in the breast.

Authors:  Cathrin Brisken; Ayyakkannu Ayyannan; Cuc Nguyen; Anna Heineman; Ferenc Reinhardt; Jian Tan; S K Dey; G Paolo Dotto; Robert A Weinberg; Tian Jan
Journal:  Dev Cell       Date:  2002-12       Impact factor: 12.270

4.  The Jak/Stat pathway: a novel way to regulate PI3K activity.

Authors:  Kathrine Abell; Christine J Watson
Journal:  Cell Cycle       Date:  2005-07-11       Impact factor: 4.534

Review 5.  The role of prolactin in mammary carcinoma.

Authors:  Charles V Clevenger; Priscilla A Furth; Susan E Hankinson; Linda A Schuler
Journal:  Endocr Rev       Date:  2003-02       Impact factor: 19.871

6.  p50alpha/p55alpha phosphoinositide 3-kinase knockout mice exhibit enhanced insulin sensitivity.

Authors:  Dong Chen; Franck Mauvais-Jarvis; Matthias Bluher; Simon J Fisher; Alison Jozsi; Laurie J Goodyear; Kohjiro Ueki; C Ronald Kahn
Journal:  Mol Cell Biol       Date:  2004-01       Impact factor: 4.272

7.  Activation of Akt-1 (PKB-alpha) can accelerate ErbB-2-mediated mammary tumorigenesis but suppresses tumor invasion.

Authors:  John N Hutchinson; Jing Jin; Robert D Cardiff; Jim R Woodgett; William J Muller
Journal:  Cancer Res       Date:  2004-05-01       Impact factor: 12.701

8.  Prolactin and transforming growth factor-beta signaling exert opposing effects on mammary gland morphogenesis, involution, and the Akt-forkhead pathway.

Authors:  Jason P Bailey; Kathryn M Nieport; Matthew P Herbst; Sunil Srivastava; Rosa A Serra; Nelson D Horseman
Journal:  Mol Endocrinol       Date:  2004-02-12

9.  Expression by transgenesis of a constitutively active mutant form of the prolactin receptor induces premature abnormal development of the mouse mammary gland and lactation failure.

Authors:  Isabelle Gourdou; Jacqueline Paly; Catherine Hue-Beauvais; Laurence Pessemesse; John Clark; Jean Djiane
Journal:  Biol Reprod       Date:  2003-11-12       Impact factor: 4.285

10.  Stat5a is tyrosine phosphorylated and nuclear localized in a high proportion of human breast cancers.

Authors:  Ion Cotarla; Shuxun Ren; Ying Zhang; Edmund Gehan; Baljit Singh; Priscilla A Furth
Journal:  Int J Cancer       Date:  2004-02-20       Impact factor: 7.316

View more
  39 in total

Review 1.  STAT signaling in polycystic kidney disease.

Authors:  Sebastian Strubl; Jacob A Torres; Alison K Spindt; Hannah Pellegrini; Max C Liebau; Thomas Weimbs
Journal:  Cell Signal       Date:  2020-04-20       Impact factor: 4.315

2.  The transcription factors signal transducer and activator of transcription 5A (STAT5A) and STAT5B negatively regulate cell proliferation through the activation of cyclin-dependent kinase inhibitor 2b (Cdkn2b) and Cdkn1a expression.

Authors:  Ji Hoon Yu; Bing-Mei Zhu; Mark Wickre; Gregory Riedlinger; Weiping Chen; Atsushi Hosui; Gertraud W Robinson; Lothar Hennighausen
Journal:  Hepatology       Date:  2010-11       Impact factor: 17.425

3.  Cyclin D3 compensates for the loss of cyclin D1 during ErbB2-induced mammary tumor initiation and progression.

Authors:  Qian Zhang; Kazuhito Sakamoto; Chengbao Liu; Aleata A Triplett; Wan-chi Lin; Hallgeir Rui; Kay-Uwe Wagner
Journal:  Cancer Res       Date:  2011-10-28       Impact factor: 12.701

4.  Mapping the zinc-transporting system in mammary cells: molecular analysis reveals a phenotype-dependent zinc-transporting network during lactation.

Authors:  Shannon L Kelleher; Vanessa Velasquez; Thomas P Croxford; Nicholas H McCormick; Veronica Lopez; Joshua MacDavid
Journal:  J Cell Physiol       Date:  2012-04       Impact factor: 6.384

Review 5.  Signal transducer and activator of transcription 5a/b: biomarker and therapeutic target in prostate and breast cancer.

Authors:  Mateusz Koptyra; Shilpa Gupta; Pooja Talati; Marja T Nevalainen
Journal:  Int J Biochem Cell Biol       Date:  2011-06-17       Impact factor: 5.085

6.  JAK/STAT inhibition in macrophages promotes therapeutic resistance by inducing expression of protumorigenic factors.

Authors:  Emily A Irey; Chelsea M Lassiter; Nicholas J Brady; Pavlina Chuntova; Ying Wang; Todd P Knutson; Christine Henzler; Thomas S Chaffee; Rachel I Vogel; Andrew C Nelson; Michael A Farrar; Kathryn L Schwertfeger
Journal:  Proc Natl Acad Sci U S A       Date:  2019-05-30       Impact factor: 11.205

Review 7.  Crosstalk between STAT5 activation and PI3K/AKT functions in normal and transformed mammary epithelial cells.

Authors:  Patrick D Rädler; Barbara L Wehde; Kay-Uwe Wagner
Journal:  Mol Cell Endocrinol       Date:  2017-05-08       Impact factor: 4.102

Review 8.  STAT signaling in mammary gland differentiation, cell survival and tumorigenesis.

Authors:  S Haricharan; Y Li
Journal:  Mol Cell Endocrinol       Date:  2013-03-28       Impact factor: 4.102

Review 9.  Mammary gland development.

Authors:  Hector Macias; Lindsay Hinck
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2012 Jul-Aug       Impact factor: 5.814

10.  Stat5 regulates the phosphatidylinositol 3-kinase/Akt1 pathway during mammary gland development and tumorigenesis.

Authors:  Jeffrey W Schmidt; Barbara L Wehde; Kazuhito Sakamoto; Aleata A Triplett; Steven M Anderson; Philip N Tsichlis; Gustavo Leone; Kay-Uwe Wagner
Journal:  Mol Cell Biol       Date:  2014-01-27       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.